1. Home
  2. CLLS vs NIPG Comparison

CLLS vs NIPG Comparison

Compare CLLS & NIPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • NIPG
  • Stock Information
  • Founded
  • CLLS 1999
  • NIPG 2014
  • Country
  • CLLS France
  • NIPG Sweden
  • Employees
  • CLLS N/A
  • NIPG N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • NIPG
  • Sector
  • CLLS Health Care
  • NIPG
  • Exchange
  • CLLS Nasdaq
  • NIPG NYSE
  • Market Cap
  • CLLS 144.4M
  • NIPG 94.5M
  • IPO Year
  • CLLS 2007
  • NIPG 2024
  • Fundamental
  • Price
  • CLLS $1.53
  • NIPG $1.59
  • Analyst Decision
  • CLLS Buy
  • NIPG Strong Buy
  • Analyst Count
  • CLLS 3
  • NIPG 1
  • Target Price
  • CLLS $7.00
  • NIPG $12.00
  • AVG Volume (30 Days)
  • CLLS 84.6K
  • NIPG 62.5K
  • Earning Date
  • CLLS 05-27-2025
  • NIPG 04-30-2025
  • Dividend Yield
  • CLLS N/A
  • NIPG N/A
  • EPS Growth
  • CLLS N/A
  • NIPG N/A
  • EPS
  • CLLS N/A
  • NIPG N/A
  • Revenue
  • CLLS $49,217,000.00
  • NIPG $85,266,306.00
  • Revenue This Year
  • CLLS $48.52
  • NIPG $20.82
  • Revenue Next Year
  • CLLS $5.17
  • NIPG $29.70
  • P/E Ratio
  • CLLS N/A
  • NIPG N/A
  • Revenue Growth
  • CLLS 435.38
  • NIPG 1.91
  • 52 Week Low
  • CLLS $1.10
  • NIPG $0.99
  • 52 Week High
  • CLLS $3.32
  • NIPG $17.76
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 56.17
  • NIPG N/A
  • Support Level
  • CLLS $1.54
  • NIPG N/A
  • Resistance Level
  • CLLS $1.65
  • NIPG N/A
  • Average True Range (ATR)
  • CLLS 0.08
  • NIPG 0.00
  • MACD
  • CLLS -0.00
  • NIPG 0.00
  • Stochastic Oscillator
  • CLLS 58.62
  • NIPG 0.00

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

About NIPG NIP GROUP INC SPON ADS EACH REPR 2 CL A ORD SHS

NIP Group Inc is a digital entertainment company built for the growing gaming and esports industry. NIP Group integrates multiple businesses such as talent agency, event production, game-themed hotels and game publishing to create transformative entertainment experiences that inspire, connect fans, expand global influence, and achieve deep interaction on platforms where digital native players gather. It currently has operation centers in Sweden, China, Abu Dhabi, and Brazil, and its esports teams cover multiple game projects and are active in the top event stages.

Share on Social Networks: